论文部分内容阅读
1 临床资料 本组60例均为我科住院患儿,全部病例均符合1987年成都会议制定的喘憋性肺炎诊断标准,其中男39例,女21例,年龄3月～1岁。60例患儿随机分为治疗组及对照组各30例,两组在年龄、性别、体质、病情等方面均无明显差异。 常规治疗两组相同(包括口服止咳化痰药、静滴维生素、氟美松、吸氧、纠酸等)。治疗组先用25％硫酸镁每次0.1～0.3g/kg,稀释成2.5％的浓度静滴,15～40滴/分(视年龄大小和病情而定),继之静滴氨茶碱每次2～4mg/kg。病情严重、喘憋症状无明显改善者。4～6小时重复静滴1次硫酸镁,用量同前。对照组静滴氨茶碱,用量同前。两组用药均不超过4天。
1 Clinical data 60 patients in our group were hospitalized children, all cases are in line with the diagnostic criteria for wheezing pneumonia in 1987 Conference in Chengdu, including 39 males and 21 females, aged 3 months to 1 year. Sixty children were randomly divided into treatment group and control group, with 30 cases in each group. There was no significant difference in age, sex, constitution, disease and other aspects between the two groups. Conventional treatment of the same two groups (including oral cough and phlegm medicine, intravenous vitamins, dexamethasone, oxygen, acid correction, etc.). Treatment group with 25% magnesium sulfate each 0.1 ~ 0.3g / kg, diluted to 2.5% concentration of intravenous infusion, 15 to 40 drops / min (depending on age and disease), followed by intravenous infusion of aminophylline per Times 2 ~ 4mg / kg. Serious illness, wheezing symptoms no significant improvement. 4 to 6 hours repeated intravenous infusion of magnesium sulfate, with the same amount. The control group intravenous aminophylline, with the same amount. Two groups of drugs are not more than 4 days.